UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005218
Receipt number R000006192
Scientific Title A phase I/II study of combination therapy with S-1/ CPT-11 plus Panitumumab as second line therapy in metastatic colorectal cancer patients with KRAS wild type
Date of disclosure of the study information 2011/03/09
Last modified on 2019/05/23 16:02:10

No. Disposal Last modified on Item of update
1 Insert 2011/03/08 13:44:38
2 Update 2019/05/23 15:58:02 Recruitment status
Date of IRB
Last follow-up date
3 Update 2019/05/23 16:00:51 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
TEL
Email


Last name of contact person
Zip code
TEL
Email
Name of primary person or sponsor
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Address2
Tel2
Email2
Address3
Tel3
Email3
Organization
Organization
Address
Address
Tel
Email
4 Update 2019/05/23 16:02:10 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures